- The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firmsLaura E Panattoni
Department of Economics, Owen G Glenn Building, The University of Auckland, Auckland, New Zealand
J Health Econ 30:126-45. 2011..I also estimate the impact of Paragraph IV decisions on brand firm profitability and find they have large value consequences...
- Do market fees differ from relative value scale fees? Examining surgeon payments in New ZealandLaura Panattoni
Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
J Health Serv Res Policy 16:203-10. 2011..Private insurance providers in New Zealand do not use a RBRVS but rather rely on a market. We explore the extent to which private surgeon fees in New Zealand are consistent with fees that would be generated by a RBRVS...